Menu Search
Equities

Thyrocare Technologies Ltd

THYROCARE:NSI

Thyrocare Technologies Ltd

Actions
Health CareMedical Equipment and Services
  • Price (INR)976.55
  • Today's Change35.55 / 3.78%
  • Shares traded140.54k
  • 1 Year change+80.18%
  • Beta0.5096
Data delayed at least 15 minutes, as of Nov 14 2024 10:01 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 16-Nov-23
  • 15-Aug-24
  • 19-Sep-24
  • 17-Oct-24
  • 07-Nov-24
Select bar for recommendation details.
Recommendations07-Nov-24
Buy0
Outperform1
Hold0
Sell0
Strong Sell0

Share price forecast in INR

The one analyst offering a 12 month price target expects the share price price of Thyrocare Technologies Ltd to remain relatively unchanged over the next year.
High-0.5%975.00
Med-0.5%975.00
Low-0.5%975.00

Dividends

In 2024, Thyrocare Technologies Ltd reported a dividend of 18.00 INR, equaling last years dividend. The analyst covering the company expects dividends of 11.20 INR for the upcoming fiscal year, a decrease of 37.78%.
Div growth (TTM)0.00%
More ▼

Earnings history & estimates in INR

On May 14, 2024, earnings of 3.54 per share.
The next earnings announcement is expected on May 12, 2025.
Average growth rate+13.95%
Thyrocare Technologies Ltd reported annual 2024 earnings of 13.40 per share on May 14, 2024.
Average growth rate+5.37%
More ▼

Revenue history & estimates in INR

Thyrocare Technologies Limited had 2nd quarter 2025 revenues of 1.77bn. This bettered the 1.73bn estimate of the one analyst covering the company. This was 31.48% above the prior year's 2nd quarter results.
Average growth rate+5.07%
Thyrocare Technologies Limited had revenues for the full year 2024 of 5.72bn. This was 8.58% above the prior year's results.
Average growth rate+7.81%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.